NCT00104728View on ClinicalTrials.gov

Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates

NATerminatedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

May 31, 2008

Study Completion Date

March 31, 2009

Conditions

Lung Cancer

Interventions

DRUG

ZD1839

Trial Locations (1)

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

AstraZeneca

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER